Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
All content for PayerTalkCE is the property of IMPACT and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Atopic Dermatitis
PayerTalkCE
42 minutes 5 seconds
9 months ago
PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Atopic Dermatitis
This podcast provides an in-depth exploration of type 2 inflammation and its role in the pathophysiology and management of atopic dermatitis, tailored for health plan professionals. Experts discuss the molecular mechanisms driving the condition, including key cytokines like IL-4 and IL-13, and highlight the clinical and quality-of-life impacts for patients. The conversation covers the evolution of targeted therapies, including biologics and JAK inhibitors, and emphasizes the importance of shared decision-making and timely treatment. Special attention is given to addressing health disparities in diagnosing and treating patients with darker skin tones, underscoring the need for equitable care strategies.This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us athttps://www.impactedu.net/ (https://www.managedcarecgm.com/diabetes-quality-and-cgm)type2-inflammation-atopic-dermatitis-management.
PayerTalkCE
Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.
